
Sign up to save your podcasts
Or
Host: Darryl S. Chutka, M.D.
Guest: Aaron M. Potretzke, M.D.
Today, we're airing a popular episode from Season 2 of Mayo Clinic Talks! Happy Holidays!
Microscopic hematuria, and less commonly gross hematuria, are conditions commonly seen by the primary care provider. Malignancy is the most ominous cause of hematuria. Fortunately, other causes are much more likely. Since this is a relatively common health condition, when should we investigate hematuria and what should the evaluation consist of? How do we evaluate a patient’s risk for urinary tract malignancy? Dr. Aaron Potretzke, a urologist at Mayo Clinic, joins us to discuss these questions.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
4.4
259259 ratings
Host: Darryl S. Chutka, M.D.
Guest: Aaron M. Potretzke, M.D.
Today, we're airing a popular episode from Season 2 of Mayo Clinic Talks! Happy Holidays!
Microscopic hematuria, and less commonly gross hematuria, are conditions commonly seen by the primary care provider. Malignancy is the most ominous cause of hematuria. Fortunately, other causes are much more likely. Since this is a relatively common health condition, when should we investigate hematuria and what should the evaluation consist of? How do we evaluate a patient’s risk for urinary tract malignancy? Dr. Aaron Potretzke, a urologist at Mayo Clinic, joins us to discuss these questions.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
134 Listeners
318 Listeners
498 Listeners
687 Listeners
255 Listeners
3,332 Listeners
90 Listeners
24 Listeners
1,105 Listeners
195 Listeners
517 Listeners
350 Listeners
12 Listeners
18 Listeners
252 Listeners
15 Listeners
9 Listeners
425 Listeners
368 Listeners
46 Listeners
14 Listeners